144 results match your criteria: "Peking University Ditan Teaching Hospital.[Affiliation]"

Background: Platelet recovery was an important prognostic indicator in severe fever with thrombocytopenia syndrome (SFTS). This study focused on risk factors affecting platelet recovery in surviving SFTS patients, which can assist clinicians in the early screening of patients associated with a greater risk of mortality.

Method: We retrospectively analyzed the clinical data of SFTS patients admitted to Yantai Qishan Hospital throughout 2023.

View Article and Find Full Text PDF

Hyaluronic Acid is Associated with Severity and Prognosis in Patients with Community-Acquired Pneumonia.

J Inflamm Res

December 2024

Department of Center of Integrated Traditional Chinese and Western Medicine, Peking University Ditan Teaching Hospital, Beijing, People's Republic of China.

Purpose: Hyaluronic acid (HA) is a novel inflammatory biomarker with a prognostic value for several infectious diseases. This study investigated the association of HA with severity and prognosis in hospitalized patients with community-acquired pneumonia (CAP).

Patients And Methods: We analyzed the differences of HA levels in different groups.

View Article and Find Full Text PDF

: Accumulating evidence has confirmed the efficacy and safety of COVID-19 vaccines against SARS-CoV-2 infection. However, the effect of COVID-19 vaccination on immuno-virological parameters in people with HIV (PWH) is uncertain. : A total of 372 PWH treated at Beijing Ditan Hospital were included.

View Article and Find Full Text PDF

Clinical analysis of infection in patients with liver cirrhosis in Beijing.

World J Hepatol

December 2024

Center of Liver Diseases Division 3, Beijing Ditan Hospital, Capital Medical University, Peking University Ditan Teaching Hospital, Beijing 100015, China.

Background: The incidence of () infection in patients with cirrhosis has been increasing over recent years, posing certain difficulties in clinical treatment.

Aim: To analyze the clinical features of patients with liver cirrhosis and identify the risk factors to help the early diagnosis and treatment of these diseases.

Methods: Clinical data and laboratory tests were collected from 72 patients with cirrhosis confirmed by secretion or blood culture of infection at Beijing Ditan Hospital, Capital Medical University, between May 2016 and October 2018.

View Article and Find Full Text PDF

The Imbalance of Homeostasis in Neutrophil Extracellular Traps is Associated with Portal Vein Thrombosis in Patients with Decompensated Cirrhosis.

J Clin Transl Hepatol

December 2024

Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.

Background And Aims: Portal vein thrombosis (PVT) is a challenging complication in liver cirrhosis, with no currently available sensitive diagnostic markers. This study aimed to investigate the potential of neutrophil extracellular traps (NETs) and Deoxyribonuclease (DNase) as diagnostic indicators for PVT in chronic hepatitis B (CHB)-related decompensated cirrhosis.

Methods: We analyzed 145 CHB-related decompensated cirrhosis patients from the Ditan study and 33 from the Changgung validation study, categorizing them based on PVT occurrence.

View Article and Find Full Text PDF

Objective: To explore any correlation between serum urate (SU) level or insulin resistance (IR) and metabolic dysfunction associated steatotic liver disease (MASLD) in patients with metabolic syndrome (MS).

Methods: Data from all MASLD patients, diagnosed by liver biopsy, were enrolled and divided into MASLD alone group and MASLD with MS group. They were subdivided into hyperuricemia group and normal SU group to find correlation between SU/IR and MASLD in patients with MS and independent risk factors for MASLD.

View Article and Find Full Text PDF

MASH Meets HBV: Age, Lifestyle, and the Untapped Role of Non-Immune Cells.

J Hepatol

November 2024

Department of Center of Integrated Traditional Chinese and Western Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China; Department of Center of Integrated Traditional Chinese and Western Medicine, Peking University Ditan Teaching Hospital, Beijing, China. Electronic address:

View Article and Find Full Text PDF

Pituitary stalk interruption syndrome complicated with liver cirrhosis: A case report.

World J Hepatol

November 2024

Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.

Background: Pituitary stalk interruption syndrome (PSIS) is a rare disorder, often characterized by delayed growth and development, short stature, and hypogonadism as the main clinical manifestations. It is not clear whether PSIS can lead to liver cirrhosis.

Case Summary: This paper reported a case of liver cirrhosis of unknown origin.

View Article and Find Full Text PDF

Association Between Retinol-Binding Protein 4 Levels and Hepatitis C Virus Infection: A Meta-Analysis.

Diseases

November 2024

Department of Center of Integrated Traditional Chinese and Western Medicine, Peking University Ditan Teaching Hospital, No. 8, Jingshun East Street, Chaoyang District, Beijing 100015, China.

: The relationship between circulating retinol-binding protein 4 (RBP4) levels and hepatitis C virus (HCV) infection remains unclear. This study aims to systematically assess RBP4 expression in patients with HCV and its correlation with disease severity. : We searched the Embase, PubMed, and Cochrane databases for relevant studies up to 1 January 2024.

View Article and Find Full Text PDF

Obesity and risk for liver disease: a two-sample Mendelian randomisation study.

Br J Nutr

November 2024

Department of Gastroenterology, Beijing Ditan Hospital, Capital Medical University, Beijing100015, People's Republic of China.

Article Synopsis
  • * Findings showed that higher genetically predicted BMI and WHRadjBMI were linked to non-alcoholic fatty liver disease, liver fibrosis, and autoimmune hepatitis, but not to other liver conditions like primary biliary cholangitis or liver cancer.
  • * The research suggested that obesity has distinct causal effects on certain liver diseases and metabolic functions, particularly non-alcoholic fatty liver disease and liver fibrosis, but not on viral or autoimmune liver diseases.
View Article and Find Full Text PDF

Advances in immunotherapy for hepatitis B virus associated hepatocellular carcinoma patients.

World J Hepatol

October 2024

Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.

Article Synopsis
  • Hepatitis B virus (HBV) infection is linked to a high incidence of hepatocellular carcinoma (HCC), especially in China, where around 92.05% of liver cancer patients are infected with HBV.
  • The immune environment around tumors (TME) changes due to HBV, allowing cancer cells to escape immune detection, often with the help of proteins like CTLA-4 and PD-1/PD-L1 that suppress T cell activity.
  • Recent advancements in immunotherapy, including treatments with interferons and PD-1/L1 inhibitors, show promise for HBV-related HCC patients, raising questions about their efficacy for Chinese patients with distinct disease characteristics.
View Article and Find Full Text PDF

Hepatitis B virus (HBV) infection poses a challenge to global public health. Persistent liver infection with HBV is associated with an increased risk of developing severe liver disease. The complex interaction between the virus and the host is the reason for the persistent presence of HBV and the risk of tumor development.

View Article and Find Full Text PDF

Clinical efficacy and safety of new compound single tablet antiviral drugs in the treatment of HIV/AIDS.

Life Sci

December 2024

Department of Center of Integrated Traditional Chinese and Western Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China. Electronic address:

Article Synopsis
  • * Results show a 100% viral suppression rate and significant increases in CD4+ T cell counts after transitioning to these therapies over a 6-month period.
  • * The therapies are deemed safe, with improvements in certain health indicators (like LDL and HDL levels) and reductions in ALT, AST, and blood glucose levels, affirming their recommendation for HIV/AIDS treatment.
View Article and Find Full Text PDF

Synergistic evolution: The dynamic adaptation of SARS-CoV-2 and human protective immunity in the real world.

J Infect

December 2024

Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China. Electronic address:

Article Synopsis
  • This study examines how the ever-evolving SARS-CoV-2 virus affects immunity from past infections and vaccines, particularly focusing on the ability to prevent re-infections and severe cases of COVID-19.
  • Researchers collected 890 serum samples from patients infected with various SARS-CoV-2 variants and tested for neutralizing antibodies (NAbs) against these variants, revealing that a significant portion of individuals developed strong immune responses.
  • The findings highlight the complex interaction between the virus and human immune responses, indicating the need for adaptive vaccine development to keep pace with the virus's mutations and ensure effective public health strategies.
View Article and Find Full Text PDF

Bioinformatics analysis and experimental validation of as a potential prognostic marker and therapeutic target for liver hepatocellular carcinoma.

Biomol Biomed

October 2024

Center of Integrative Medicine, Peking University Ditan Teaching Hospital, Beijing, China; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.

Article Synopsis
  • The C6orf120 gene is a newly identified gene linked to liver diseases, and its specific function in liver cancer (LIHC) is not yet fully understood.
  • This study used bioinformatics tools and clinical data to find that C6orf120 is elevated in LIHC and may be a valuable diagnostic and prognostic biomarker.
  • Experimental results showed that reducing C6orf120 levels in liver cancer cells decreases their ability to migrate but does not affect their growth, indicating its potential role in cancer spread and as a target for treatment.
View Article and Find Full Text PDF
Article Synopsis
  • Acute hepatitis E virus (HEV) infection is a significant global health issue leading to high rates of illness and death; this study focused on the clinical features and outcomes of affected patients.
  • Researchers analyzed data from 628 patients diagnosed with acute HEV from 2014 to 2022, noting that most were middle-aged males and observed elevated liver enzymes and bilirubin levels.
  • Key findings revealed that patients with liver cirrhosis had worse outcomes, with liver cirrhosis and low albumin levels identified as major predictors of poor prognosis in acute HEV cases.
View Article and Find Full Text PDF

Inhibition of ethanol-induced eNAMPT secretion attenuates liver ferroptosis through BAT-Liver communication.

Redox Biol

September 2024

Department of Nutrition, Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong, China. Electronic address:

Background & Aims: Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) has long been recognized as an adipokine. However, the exact role of eNAMPT in alcoholic liver disease (ALD) and its relevance to brown adipose tissue (BAT) remain largely unknown. This study aimed to evaluate the impact of eNAMPT on liver function and the underlying mechanisms involved in BAT-Liver communication.

View Article and Find Full Text PDF

Knockout of in Rats Alleviates Concanavalin A-induced Autoimmune Hepatitis by Regulating Macrophage Polarization.

Biomed Environ Sci

June 2024

Department of Center of Integrated Traditional Chinese and Western Medicine, Peking University Ditan Teaching Hospital, Beijing 100015, China;Department of Center of Integrated Traditional Chinese and Western Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.

Objective: The effect of the functionally unknown gene on autoimmune hepatitis was investigated on knockout rats ( ) and THP-1 cells.

Method: Six-eight-week-old and wild-type (WT) SD rats were injected with Con A (16 mg/kg), and euthanized after 24 h. The sera, livers, and spleens were collected.

View Article and Find Full Text PDF

Association of Cytokines with Clinical Indicators in Patients with Drug-Induced Liver Injury.

Biomed Environ Sci

May 2024

Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China;Department of Hepatology Division 2, Peking University Ditan Teaching Hospital, Beijing 100015, China.

Article Synopsis
  • The study aimed to investigate the clinical characteristics and cytokine levels in patients with drug-induced liver injury (DILI) from various drug categories, assessing how these factors correlate with clinical indicators.
  • A total of 73 patients were categorized based on the type of drug causing DILI, revealing significant differences in liver enzyme levels between groups, particularly higher alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in NSAIDs users compared to those using Chinese herbal medicines.
  • The findings suggest older patients are more susceptible to DILI, and higher levels of inflammation markers (IL-6 and TNF-α) in NSAIDs patients could be linked to more severe liver damage.
View Article and Find Full Text PDF

Background: Liuweiwuling Tablet (LWWL) is a Chinese patent medicine approved for the treatment of chronic inflammation caused by hepatitis B virus (HBV) infection. Previous studies have indicated an anti-HBV effect of LWWL, specifically in terms of antigen inhibition, but the underlying mechanism remains unclear.

Aim: To investigate the potential mechanism of action of LWWL against HBV.

View Article and Find Full Text PDF

Relationship between Phenotypic Changes of Dendritic Cell Subsets and the Onset of Plateau Phase during Intermittent Interferon Therapy in Patients with CHB.

Biomed Environ Sci

March 2024

Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China;Department of Hepatology Division 2, Peking University Ditan Teaching Hospital, Beijing 100015, China.

Article Synopsis
  • - The study investigated the relationship between dendritic cell subsets and the decline of hepatitis B surface antigens in chronic hepatitis B patients undergoing intermittent interferon therapy.
  • - It categorized patients into three groups: a natural history group, a long-term nucleoside analogs treatment group, and a plateau-arriving group, measuring dendritic cells and costimulatory molecules using flow cytometry.
  • - Findings revealed that the plateau group had significantly lower levels of certain dendritic cells and costimulatory molecule expression, suggesting these reductions may be linked to the plateau phase in treatment response.
View Article and Find Full Text PDF

Hepatitis B virus (HBV) infection poses a significant burden on global public health. Unfortunately, current treatments cannot fully alleviate this burden as they have limited effect on the transcriptional activity of the tenacious covalently closed circular DNA (cccDNA) responsible for viral persistence. Consequently, the HBV life cycle should be further investigated to develop new anti-HBV pharmaceutical targets.

View Article and Find Full Text PDF

Purpose: The primary aim of this study was to closely monitor and identify adverse events (AEs) linked to lenvatinib, a pharmacotherapeutic agent employed for the management of renal cell carcinoma, thyroid cancer, and hepatocellular carcinoma. The ultimate goal was to optimize patient safety and provide evidence-based guidance for the appropriate utilization of this medication.

Methods: A comprehensive collection and analysis of reports from the FDA Adverse Event Reporting System (FAERS) database was conducted, encompassing the period from the first quarter of 2015 to the first quarter of 2023.

View Article and Find Full Text PDF

Novel protein C6ORF120 promotes liver fibrosis by activating hepatic stellate cells through the PI3K/Akt/mTOR pathway.

J Gastroenterol Hepatol

July 2024

Department of Center of Integrated Traditional Chinese and Western Medicine, Peking University Ditan Teaching Hospital, Beijing, China.

Background And Aim: The role of C6ORF120 in promoting CCL4-induced hepatic fibrosis and its possible mechanisms were explored in C6orf120 knockout rats (C6orf120) and LX-2 cells (a type of human hepatic stellate cell line).

Methods: In vivo experiments, wild-type and C6orf120 rats were used to investigate the function of C6ORF120. In the in vitro experiments, C6ORF120 recombinant protein (rC6ORF120) at a concentration of 200 ng/mL was used to stimulate LX-2 cells.

View Article and Find Full Text PDF